Simian virus 40 (SV40) early pre-mRNA is spliced using either of two alternative 5' splice sites and a common 3' splice site to produce two mRNAs that encode the T and t antigens. We have studied alternative splicing of SV40 early pre-nRNA in vitro using a He La cell nuclear extract. Synthetic SV40 early transcripts are processed to T and t antigen mRNAs In vitro. As in SV40-infected cells in vivo, cleavage at the T antigen 5' splice site is more efficient than cleavage at the t antigen 5' splice site in vitro, although both of these 5' splice sites are utilized relatively inefficiently In vitro. The ratio of cleavage at the T and t antigen 5' splice sites is not changed significantly, by a number of alterations in the conditions under which the in vitro splicing reactions are carried out.
INTRODUCTION
Most higher eukaryotic genes contain intervening sequence* (IVSs) that interrupt protein coding regions.
During maturation of nuclear mRNA precursor transcripts (pre-mRNAs) to mRNAs the intervening sequences are excised and the exons ligated, a process known as RNA splicing. In some cases, a single transcript can be spliced using different combinations of splice sites, sometimes in a tissue-specific manner, yielding multiple mRNAs that encode different proteins. Thus, regulation of gene expression can occur at the level of alternative pre-mRNA splicing.
Simian virus 40 (SV40) early transcripts are spliced using either of two alternative 5' splice sites and a common 3' splice site (reviewed in 1).
The resultant mRNAs encode the T and t antigens (see Figure 1 ). The t antigen 5' splice site is 269 bases downstream of the T antigen 5' splice site; the T and t antigen polypeptides thus share a common amino-terminus and diverge at their carboxyl-termini. The proportion of T to t antigen mRNAs in SV40 infected cells (approximately 4:1) does not appear to be regulated by viral products and does not change over the course of SV40 lytic infection. However, the ratio of T to t antigen mRNAs is affected by the temperature at which infected or transformed cells are grown (2) and by deletions between the T and t antigen 5' splice sites (3) .
©IRL Press Limited, Oxford, England. "
We have used a HeLa nuclear extract system (4) to study alternative splicing of SV40 early pre-mRNA in vitro.
We have found that alternative splicing of SV40 early pre-mRNA occurs in vitro. The efficiency of splicing SV40 early pre-mRNA in vitro is low, and the ratio of T and t antigen mRKAs produced in vitro is somewhat higher than In vivo. The efficiencies of cleavage at the T and t antigen 5' splice sites were only partially related to their relative positions in the transcript. The conditions for optimal utilization of the T and t antigen 5' splice sites in vitro are the same; a number of alterations in the conditions at which the in vitro splicing reactions are carried out do not significantly alter the ratio of cleavage at the T and t antigen 5' splice sites.
MATERIALS Mfi METHODS

Transcriptlonal template plasmlds
Plasmld pSP6SVE (see Figure 1 ) was constructed by ligatlng a 2.7-kb Xho I-BamH I fragment from pX-8 (5) containing the early region of SV40 to a Sal I-BamH I fragment from pSD346A (P. Good, personal com.), a derivative of pSP64 (6) containing a 100-base poly(A) tract downstream of the unique BamH I cleavage site. The segment between the Hind III and Pst I sites of the pSP64 polylinker (sequence AGCTTGGGCTGCA) was deleted to reduce the distance between the SP6 transcriptlonal initiation site and the SV40 sequences.. Plasmid pSP6SVEASB (see Figure 1 ) is analogous to pSP6SVE, but the segment between SV40 nucleotldes 4766 and 5192 that includes the T antigen 5' splice site has been deleted.
In vitro transription. splicing, and RfiA. analyses
Prior to transcription, pSP6SVE and pSP6SVEASB DNAs were cleaved at the Bgl II site immediately 3' to the poly(A) tract. Template DNAs were then transcribed with SP6 RNA polymerase (Promega) as previously described (7) In the presence of G(5')ppp(5')G (PL Biochemlcals), and full-length transcripts were purified by oligo(dT)cellulose column chromatography. Mlcroinjection of transcripts into Xenopus oocytes (8) , preparation of HeLa cell nuclear extracts (9) , and In vitro splicing reactions (4) were exactly as described.
In vitro splicing was carried out at 30° C in 60 mM KC1, 3. were as previously described (7) . T antigen and t antigen cDNA plasmids pSVT#5 and pSVt were the kind gifts of Y. Gluzman and J. Manley, respectively. Relative intensies of bands on autoradiograms were determined using a Hoefer GS300 scanning densitometer.
RESULTS
Synthetic SV40 early pre-mRNA can b_e. cleaved a_£ both the I and. £ antigen 5_I splice sites in Xenopus oocvtes Capped and polyadenylated SV40 early pre-mRNA was synthesized using SP6 RNA polymerase with pSP6SVE as template. In vivo SV40 early mRNA contains multiple 5' termini (5,12,13), and the relationship between specific 5' termini and splicing pattern of SV40 early transcripts has not been established. Therefore, because pSP6SVE transcripts contain a unique 5' terminus, i t was necessary to determine whether pSPSVE transcripts can be cleaved at both the T and t antigen 5' splice sites. Accordingly, pSP6SVE transcripts were microinjected Into Xenopus oocyes and RNA was prepared after 6 hrs. To assay for transcript cleavage at the T and t antigen 5' splice sites, we performed SI nuclease analysis using as probe a 1732 bp double-stranded 3' end-labeled Xho I-Pvu II DNA fragment from pX-8 (5). As shown in Figure 2 , pSP6SVE transcripts were cleaved at both the T antigen (323-base protected fragment) and t antigen (603-base protected fragment) 5' splice sites in Jenopus oocytes.
The ratio of cleavage at the T and t antigen 5' splice sites was approximately 1:8, similar to that observed when SV40 DNA i s introduced into Xenopus oocytes (14) . These data demonstrate that pSP6SVE transcripts (containing only a single 5' terminus) can be cleaved at both the T and t antigen 5' splice sites.
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As shown in Figure 5A , transcript cleavage at the SV40 early 3' splice site The conditions for optimal cleavage at the I and £ antigen 5' splice sites in vitro are similar The proportions of SV40 early transcripts cleaved at the T and t antigen 5' splice sites might be affected by alterations in the conditions of the splicing reaction. To test this hypothesis, we carried out in vitro splicing reactions using both pSP6SVE and pSP6SVEASB transcripts in which we varied a number of different parameters.
These included varying the concentration of KC1, MgCl , or ATP, varying the temperature of incubation, pre-heating the HeLa nuclear extract at 45° C for 30 min, or including anti-(Ul)RNP antisera (17,18) or vanadyl rlbonucleoside complexes (19) in the in vitro splicing reactions.
As shown In Figure 7 , each of these manipulations affected in vitro cleavage of pSP6SVE transcripts at the T antigen 5' splice site similarly to cleavage at the t antigen 5' splice site. Cleavages at the T and t antigen 5' splice sites were assayed by SI nuclease analysis using the Xho I-Pvu II and Taq I-Hind III probes described above. Cleavage at both the T antigen 5 to 8), and 30°C (lanes 1 to 4) , and Is inhibited by pre-treatment of the HeLa cell nuclear extract at 45°C for 30 mln (lanes 9 versus 14) , the inclusion of 1 mM vanadyl ribonucleoslde complexes (lanes 9 versus 13), or anti-(Ul)RNP antiserum (lanes 15 to 17) . Preincubation of the HeLa nuclear extract with anti-(Ul)RNP antisera for longer than 30 min also failed to completely abolish splicing activity for SV40 early and also human 0-and 7-globin pre-mRNAs (data not shown). We also observed essentially identical effects of all of these manipulations on cleavage of pSP6SVEASB transcripts at the t antigen 5' splice site (data not shown).
Thus, these results indicate that cleavages at the T antigen and t antigen 5' splice sites occur under similar optimal conditions in vitro for those parameters that we tested.
DISCUSSION
We In contrast, only a few percent of pSP6SVE transcripts are processed to T and t antigen mRNA over a comparable period. Thus, the majority of pSP6SVE transcripts are unspliced in vitro, possibly because the sequences at the T and t antigen 5' splice sites are poor substrates for the splicing reaction.
In transcripts that lack a "good" 5' splice site, utilization of several "poor" sites may then occur, and various splices that occur at a low rate may represent a significant fraction of the total. Therefore, utilization of the T and t antigen 5' splice sites nay occur by an essentially stochastic process that can be modified by cellular factors.
